Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years

被引：36

作者：

Cuzin, Lise ^{[1
]}

Delpierre, Cyrille ^{[1
]}

Gerard, Stephane ^{[1
]}

Massip, Patrice ^{[1
]}

Marchou, Bruno ^{[1
]}

机构：

[1] Hop Purpan, Dept Infect & Trop Dis, F-31059 Toulouse 9, France

来源：

CLINICAL INFECTIOUS DISEASES | 2007年 / 45卷 / 05期

关键词：

D O I：

10.1086/520652

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We analyzed the effect of age on highly active antiretroviral therapy efficacy and tolerance in 639 patients with human immunodeficiency virus (HIV) infection (99 of whom were aged > 50 years, and 540 of whom were aged > 50 years). Late testing, which was more frequent in the older age group, was the only independent factor associated with immunologic and clinical evolution of infection. Age > 50 years was associated with earlier treatment discontinuation.

引用

页码：654 / 657

页数：4

共 12 条

[1] Perspective on HIV infection and aging: Emerging research on the horizon [J].

Casau, NC .

CLINICAL INFECTIOUS DISEASES, 2005, 41 (06) :855-863

[2] High-risk groups for late diagnosis of HIV infection: A need for rethinking testing policy in the general population [J].

Delpierre, Cyrille ;

Cuzin, Lise ;

Lauwers-Cances, Valerie ;

Marchou, Bruno ;

Lang, Thierry .

AIDS PATIENT CARE AND STDS, 2006, 20 (12) :838-847

[3] Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].

Egger, M ;

May, M ;

Chêne, G ;

Phillips, AN ;

Ledergerber, B ;

Dabis, F ;

Costagliola, D ;

Monforte, AD ;

de Wolf, F ;

Reiss, P ;

Lundgren, JD ;

Justice, AC ;

Staszewski, S ;

Leport, C ;

Hogg, RS ;

Sabin, CA ;

Gill, MJ ;

Salzberger, B ;

Sterne, JAC .

LANCET, 2002, 360 (9327) :119-129

[4] Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV [J].

Grabar, S ;

Kousignian, I ;

Sobel, A ;

Le Bras, P ;

Gasnault, J ;

Enel, P ;

Jung, C ;

Mahamat, A ;

Lang, JM ;

Costagliola, D .

AIDS, 2004, 18 (15) :2029-2038

[5] HIV infection in older patients in the HAART era [J].

Grabar, S ;

Weiss, L ;

Costagliola, D .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) :4-7

[6] Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy [J].

Grimes, RM ;

Otiniano, ME ;

Rodriguez-Barradas, MC ;

Lai, DJ .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (11) :1530-1533

[7] Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up [J].

Knobel, H ;

Guelar, A ;

Valldecillo, G ;

Carmona, A ;

González, A ;

López-Colomés, JL ;

Saballs, P ;

Gimeno, JL ;

Díez, A .

AIDS, 2001, 15 (12) :1591-1593

[8] A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age [J].

Manfredi, R ;

Chiodo, F .

AIDS, 2000, 14 (10) :1475-1477

[9] Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients [J].

Orlando, G. ;

Meraviglia, P. ;

Cordier, L. ;

Meroni, L. ;

Landonio, S. ;

Giorgi, R. ;

Fasolo, M. ;

Faggion, I. ;

Riva, A. ;

Zambelli, A. ;

Beretta, R. ;

Gubertini, G. ;

Dedivitiis, G. ;

Jacchetti, G. ;

Cargnel, A. .

HIV MEDICINE, 2006, 7 (08) :549-557

[10] Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers [J].

Sabin, CA ;

Smith, CJ ;

Youle, M ;

Lampe, FC ;

Bell, DR ;

Puradiredja, D ;

Lipman, MCI ;

Bhagani, S ;

Phillips, AN ;

Johnson, MA .

AIDS, 2006, 20 (01) :67-71

← 1 2 →

Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged &gt;50 years

Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years